Large Molecule Bioanalysis Services

Accelerate your drug development program with Pharmaron’s comprehensive Small Molecule Bioanalysis services. Empower your biologics and advanced therapeutic development with Pharmaron’s specialized Large Molecule Bioanalysis services. With robust platforms and over 20 years of regulatory experience, we provide precise and efficient bioanalytical support for PK, TK, PD, immunogenicity, biodistribution, and biomarker assays across discovery, preclinical, and clinical phases.

Key highlights from this brochure include:

• Comprehensive Capabilities: Expertise in ligand-binding assays, ADA and NAb analysis, immunophenotyping, and multiplex immunoassays for a wide range of large molecule therapeutics.
• Cutting-Edge Technologies: Leverage platforms like ELISA, MSD?, Luminex?, Gyrolab?, and flow cytometry for high-quality data tailored to regulatory standards.
• Regulatory Excellence: Successfully audited by FDA, EMA, MHRA, and more, with over 20 IND-enabling packages for large molecule bioanalysis submitted annually.

From antibodies and ADCs to cell and gene therapy products, Pharmaron’s bioanalysis solutions deliver the insights you need to accelerate development and achieve regulatory approval.

Download the brochure today and see how our expertise can support your pipeline.